These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1009851)

  • 21. Toxic epidermal necrolysis following measles vaccination.
    Shoss RG; Rayhanzadeh S
    Arch Dermatol; 1974 Nov; 110(5):766-70. PubMed ID: 4418234
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylactic paracetamol with childhood immunisation?
    Drug Ther Bull; 1990 Sep; 28(19):73-4. PubMed ID: 2131221
    [No Abstract]   [Full Text] [Related]  

  • 23. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with vaccination against measles in Czech regions].
    Adam E; Domoráková E; Kratochvílová M; Burian V; Janotová J; Drevo M; Verhun V; Doubková S; Hartl J
    Cesk Pediatr; 1970 Sep; 25(9):438-40. PubMed ID: 5455607
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles].
    Domorázková E; Janotová J; Vodicková M; Drevo M
    Cesk Pediatr; 1975 Oct; 30(10):468-70. PubMed ID: 1212713
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination of college students with attenuated live measles vaccine.
    Mitus A
    N Engl J Med; 1985 May; 312(20):1326. PubMed ID: 3990732
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled observation on the incidence of disease and post-vaccinal reactions in children during the three-week period following the beginning of vaccination with live measles vaccine developed by the Academy of Medical Sciences of the USSR from strain EShCh].
    Siniak KM; Chumakov MP; Voroshilova MK; Livanova LV; Zlatkovskaia NM; Ralko LP; Rodin VI; Bulyga MS; Boĭko VM; Karaseva IA; Maksumov SS; Dzhalalov KhD; Varsanova EIa; Miasnikova DE; Makhmudov OS
    Vopr Virusol; 1967; 12(4):406-15. PubMed ID: 5611746
    [No Abstract]   [Full Text] [Related]  

  • 28. [Side effects of the use of the preventive mixed mumps, rubella and measles vaccine inchildren of the City of São Paulo].
    Konichi SR; Laus WC; Mattos CA; Amato Neto V; Aly J; Finger H; Bianchi A
    Rev Inst Med Trop Sao Paulo; 1973; 15(3):161-4. PubMed ID: 4732747
    [No Abstract]   [Full Text] [Related]  

  • 29. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 30. [Repercussions of vaccination against measles].
    Guerrero EV; Calderón C; Velázquez Franco E
    Salud Publica Mex; 1974; 16(5):707-20. PubMed ID: 4456647
    [No Abstract]   [Full Text] [Related]  

  • 31. [Unusual complications of poliomyelitis vaccination].
    Dietzsch HJ; Kiehl W
    Kinderarztl Prax; 1983 Nov; 51(11):513-6. PubMed ID: 6668797
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 34. [Side effects and complications of measles-mumps vaccination].
    von Mühlendahl KE
    Monatsschr Kinderheilkd; 1989 Aug; 137(8):440-6. PubMed ID: 2682212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vaccination against measles--adverse effects, cause of reduced protective effect in investigated material].
    Enell H; Simonsson H
    Lakartidningen; 1973 Sep; 70(39):3357-8. PubMed ID: 4788642
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of antibody response following measles vaccination.
    Med J Aust; 1968 Mar; 1(12):489-91. PubMed ID: 5647361
    [No Abstract]   [Full Text] [Related]  

  • 39. Polio vaccine and polio.
    Preiser G
    Pediatrics; 1999 Mar; 103(3):695; author reply 695-6. PubMed ID: 10189299
    [No Abstract]   [Full Text] [Related]  

  • 40. [The side effects of the vaccination of 650 children against measles].
    Bengtsson B
    Lakartidningen; 1971 May; 68(19):2235-44. PubMed ID: 5579712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.